Meningeal Carcinomatosis

DBCOND0003172NeoplasmsNervous System Diseases

Meningeal Carcinomatosis is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Metastases to meninges · nonleukemic meningeal cancer · Carcinomatous Meningitis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0520188SNOMED CT230156002MedDRA10051696UMLSC0220654

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
121Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Meningeal Carcinomatosis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In